Publicaciones en colaboración con investigadores/as de University Hospital of Lausanne (17)

2014

  1. Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: Design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial

    Journal of Hypertension, Vol. 32, Núm. 9, pp. 1888-1897

  2. Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: A review of available trial evidence

    Journal of Hypertension, Vol. 32, Núm. 9, pp. 1741-1750

2013

  1. 2013 ESH/ESC guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

    European Heart Journal, Vol. 34, Núm. 28, pp. 2159-2219

2009

  1. Amlodipine and valsartan as components of a rational and effective fixed-dose combination

    Vascular Health and Risk Management, Vol. 5, pp. 165-174

  2. Discrepancies between Office and Ambulatory Blood Pressure: Clinical Implications

    American Journal of Medicine, Vol. 122, Núm. 12, pp. 1136-1141

  3. Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension

    Journal of Hypertension, Vol. 27, Núm. 4, pp. 673-679

  4. Fixed-dose combinations as initial therapy for hypertension: A review of approved agents and a guide to patient selection

    Drugs, Vol. 69, Núm. 13, pp. 1761-1776

  5. Manažment pacientov s diabetom 2. Typu a hypertenziou - Príliš neskoro a málo účinne: Návrh zlepšenia

    Kardiologia, Vol. 18, Núm. 6, pp. 286-293

  6. Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force document

    Journal of Hypertension, Vol. 27, Núm. 11, pp. 2121-2158

  7. Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force documental

    Blood Pressure, Vol. 18, Núm. 6, pp. 308-347

  8. Target organ damage: How to detect it and how to treat it?

    Journal of Hypertension, Vol. 27, Núm. SUPPL. 3

  9. The ADVANCE trial: Clarifying the role of perindopril/indapamide fixed-dose combination in the reduction of cardiovascular and renal events in patients with diabetes mellitus

    American Journal of Cardiovascular Drugs, Vol. 9, Núm. 5, pp. 283-291

2008

  1. The management of the type 2 diabetic patient with hypertension - Too late and too little: Suggested improvements

    Blood Pressure, Vol. 17, Núm. 5-6, pp. 250-259

2007

  1. The need for combination antihypertensive therapy to reach target blood pressures: What has been learned from clinical practice and morbidity-mortality trials?

    International Journal of Clinical Practice, Vol. 61, Núm. 9, pp. 1592-1602

2005

  1. Angiotensin receptor blockers: Therapeutic targets and cardiovascular protection

    Blood Pressure, Vol. 14, Núm. 4, pp. 196-209

2002

  1. ACE inhibition and cardiovascular mortality and morbidity in essential hypertension: The end of the search or a need for further investigations?

    American Journal of Hypertension

2001

  1. Diabetes and hypertension

    Blood Pressure, Vol. 10, Núm. 5-6, pp. 311-321